Literature DB >> 22857827

The current management of the neurogenic bladder in children with spina bifida.

Dominic Frimberger1, Earl Cheng, Bradley P Kropp.   

Abstract

The urological care of the neurogenic bladder consists of 2 components: medical management with preservation of renal function and quality-oflife issues with achieving dryness and independence of bladder and bowel management. Both components are equally important for patients to live a healthy and fulfilled life. This report explores the diagnosis of the neurogenic bladder; quality-of-life issues that caregivers and patients should expect; the importance of primary care knowledge of the neurogenic bladder and treatment; surgical options; the transition of pediatric patients to adult care; and the importance of caregiver and patient understanding of their disease, treatment options, and responsibilities.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22857827     DOI: 10.1016/j.pcl.2012.05.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  10 in total

Review 1.  Management of Neurogenic Bladder.

Authors:  Venkataramani Sripathi; Aparajita Mitra
Journal:  Indian J Pediatr       Date:  2017-05-29       Impact factor: 1.967

2.  Longitudinal Study of Bladder Continence in Patients with Spina Bifida in the National Spina Bifida Patient Registry.

Authors:  Tiebin Liu; Lijing Ouyang; Judy Thibadeau; John S Wiener; Jonathan C Routh; Heidi Castillo; Jonathan Castillo; Kurt A Freeman; Kathleen J Sawin; Kathryn Smith; Alexander Van Speybroeck; Rodolfo Valdez
Journal:  J Urol       Date:  2017-11-11       Impact factor: 7.450

3.  Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study.

Authors:  Jung Hoon Lee; Kyoung Rok Kim; Yong Seung Lee; Sang Won Han; Kun Suk Kim; Sang Hoon Song; Minki Baek; Kwanjin Park
Journal:  Korean J Urol       Date:  2014-11-28

4.  Outcomes of Intradetrusor OnabotulinumtoxinA Injection in Adults with Congenital Spinal Dysraphism in Tertiary Transitional Urology Clinic.

Authors:  Aaron Kaviani; Rashmi Pande; Timothy B Boone; Rose Khavari
Journal:  Urol Pract       Date:  2018-07-04

5.  In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction.

Authors:  Anne Steins; Pieter Dik; Wally H Müller; Stephin J Vervoort; Kerstin Reimers; Jörn W Kuhbier; Peter M Vogt; Aart A van Apeldoorn; Paul J Coffer; Koen Schepers
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

6.  The association of age of toilet training and dysfunctional voiding.

Authors:  Steve J Hodges; Kyle A Richards; Ilya Gorbachinsky; L Spencer Krane
Journal:  Res Rep Urol       Date:  2014-10-03

Review 7.  Uronephrological outcomes of patients with neural tube defects. Does a spina bifida clinic make a difference?

Authors:  Hamdan H Al-Hazmi; Mahmoud S Trbay; Abdulmonem B Gomha; Ahmad A Elderwy; Amenah J Khatab; Khalid F Neel
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

8.  Renal Outcomes in Children with Operated Spina Bifida in Uganda.

Authors:  Helen J Sims-Williams; Hugh P Sims-Williams; Edith Mbabazi Kabachelor; Benjamin C Warf
Journal:  Int J Nephrol       Date:  2018-08-07

Review 9.  Preventing kidney injury in children with neurogenic bladder dysfunction.

Authors:  Faezeh Javadi Larijani; Mastaneh Moghtaderi; Nilofar Hajizadeh; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2013-12

Review 10.  Follow-up urodynamics in patients with neurogenic bladder.

Authors:  Sanjay Sinha
Journal:  Indian J Urol       Date:  2017 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.